As a small or medium biotech company, how do you compete in a world of big pharma and their deep pockets? How do prescribers learn about your product as much as they know about big pharma products? Why aren't patients asking for your solutions by name like they do about big pharma products? Why isn't the medical community buzzing about your company and your incredible breakthroughs like they do with just about any big pharma launch? How is it that regulators and payors are approving and reimbursing more pharma products and deepening their pockets, while your innovations go unnoticed and unapproved? Why do you have to wait for big pharma to notice you, buy you out, and then maybe develop your breakthrough innovation? Can you get as many sales reps in front of doctors as they do? Do you have as big a presence at conferences as they have? Can you pump out as many publications supporting your breakthroughs as they do? Do you get the recognition your research and treatment solutions are worthy of? Having a superior product is not enough. Demonstrating fewer days in the hospital, or a reduced side-effect profile is just an endpoint. Patients, physicians, and payors need to know about your breakthroughs, your product offerings, and why you're better than anything else on the market. The Medical Communications space is disproportionately skewed to favor big pharma companies that take the lion's share of publicity and recognition; not always because their innovations are superior, but because they can shout their message louder than small & medium biotech companies. In this slide-deck, we present a model to bring small & medium biotech companies one step closer to fair competition with their big pharma counterparts. We propose the first platform to provide affordable medical writing with guaranteed quality, and built-in compliance. Educate your customers and payors with top-quality publications, posters, & presentations. We're accepting early access sign-ups by February 27th here: http://lnc.hr/d5Twk